^
    8ms
    TSN222 in Subjects With Advanced Solid Tumors or Lymphomas (clinicaltrials.gov)
    P1/2, N=162, Recruiting, Tyligand Bioscience (Shanghai) Limited | Not yet recruiting --> Recruiting
    Enrollment open • Metastases
    |
    BRAF (B-raf proto-oncogene)
    |
    BRAF mutation
    |
    TSN222
    over1year
    TSN222 in Subjects With Advanced Solid Tumors or Lymphomas (clinicaltrials.gov)
    P1/2, N=162, Not yet recruiting, Tyligand Bioscience (Shanghai) Limited
    New P1/2 trial
    |
    BRAF (B-raf proto-oncogene)
    |
    BRAF mutation
    |
    TSN222